--- title: "US IPO Weekly Recap: CRISPR biotech pops 44% as more names join the IPO pipeline" type: "News" locale: "en" url: "https://longbridge.com/en/news/293800436.md" description: "Scribe Therapeutics priced its IPO at $129 million, surging 44% as it develops CRISPR-based cardiovascular therapies. Meanwhile, defense tech firm Lyntris filed for a $300M offering. The week saw four SPACs join the pipeline, including Bluerock Acquisition II and K2 Capital Acquisition II. Market data shows the Renaissance IPO Index up 16.7% YTD, outperforming the S&P 500." datetime: "2026-07-24T21:34:48.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293800436.md) - [en](https://longbridge.com/en/news/293800436.md) - [zh-HK](https://longbridge.com/zh-HK/news/293800436.md) generator: "portal-rs" --- # US IPO Weekly Recap: CRISPR biotech pops 44% as more names join the IPO pipeline One IPO priced this past week, joined by four SPACs. Cardiovascular disease biotech **Scribe Therapeutics** (SCTX) upsized and priced at the high end to raise $129 million at a $273 million market cap. Scribe is developing in vivo CRISPR-based therapies, with an initial focus on cardiovascular and metabolic disease. Its lead candidate uses an epigenetic silencing approach to durably lower LDL-C by repressing PCSK9 expression, without permanently altering DNA. It's currently in a first-in-human trial in Australia under TGA clearance, with initial data expected in the first half of 2027. Scribe popped 44%. Two sizable issuers joined the IPO pipeline, led by defense tech firm **Lyntris** (LYNX), which filed for an estimated $300 million offering. | 7 Filings During the Week of July 20th, 2026 | | | | | ----------------------------------------------------------------------------- | ----- | ----------- | ---------------- | | Bluerock Acquisition II (BRRKU) | $150M | SPAC | BTIG | | *Blank check company backed by Bluerock targeting Web3 businesses.* | | | | | K2 Capital Acquisition II (KIIU) | $150M | SPAC | D. Boral Capital | | *Blank check company targeting national defense and critical infrastructure.* | | | | | Lyntris (LYNX) | $300M | Industrials | Evercore ISI | | *Provides defense tech connectivity solutions for military operations.* | | | | | NorthStrive Acquisition I (NOSU.RC) | $100M | SPAC | D. Boral Capital | | *Blank check company targeting manufacturing companies.* | | | | | Pinnacle Acquisition (PNAQ.U) | $200M | SPAC | Santander | | *Blank check company targeting commercial and consumer finance businesses.* | | | | | Gravitics (GVTX) | $125M | Industrials | Lucid Cap. Mkts. | | *Develops large space structures and orbital systems.* | | | | | TCGX Acquisition (TCGX) | $75M | SPAC | Jefferies | | *Blank check company formed by TCGX executives targeting healthcare in Asia.* | | | | **IPO Market Snapshot** The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 7/23/2026, the Renaissance IPO Index was up 16.7% year-to-date, while the S&P 500 was up 8.9%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Astera Labs (ALAB) and CoreWeave (CRWV). The Renaissance International IPO Index was up 38.7% year-to-date, while the ACWX was up 12.9%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Galderma and CATL. ### Related Stocks - [KTWO.US](https://longbridge.com/en/quote/KTWO.US.md) - [BLRK.US](https://longbridge.com/en/quote/BLRK.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [SPY.US](https://longbridge.com/en/quote/SPY.US.md) - [IVV.US](https://longbridge.com/en/quote/IVV.US.md) - [VOO.US](https://longbridge.com/en/quote/VOO.US.md) - [SPLG.US](https://longbridge.com/en/quote/SPLG.US.md) - [SPXL.US](https://longbridge.com/en/quote/SPXL.US.md) - [UPRO.US](https://longbridge.com/en/quote/UPRO.US.md) - [SSO.US](https://longbridge.com/en/quote/SSO.US.md) - [SH.US](https://longbridge.com/en/quote/SH.US.md) - [SPXS.US](https://longbridge.com/en/quote/SPXS.US.md) - [SPXU.US](https://longbridge.com/en/quote/SPXU.US.md) - [SDS.US](https://longbridge.com/en/quote/SDS.US.md) - [SPYI.US](https://longbridge.com/en/quote/SPYI.US.md) - [JEPI.US](https://longbridge.com/en/quote/JEPI.US.md) - [XYLD.US](https://longbridge.com/en/quote/XYLD.US.md) - [IPO.US](https://longbridge.com/en/quote/IPO.US.md) - [ALAB.US](https://longbridge.com/en/quote/ALAB.US.md) - [CRWV.US](https://longbridge.com/en/quote/CRWV.US.md) - [ACWX.US](https://longbridge.com/en/quote/ACWX.US.md) - [IPOS.US](https://longbridge.com/en/quote/IPOS.US.md) - [300750.CN](https://longbridge.com/en/quote/300750.CN.md) - [HCCD.SG](https://longbridge.com/en/quote/HCCD.SG.md) - [03750.HK](https://longbridge.com/en/quote/03750.HK.md) ## Related News & Research - [High-Yield ETFs for Retirement: Why JEPI, QQQI Could Come with a Catch](https://longbridge.com/en/news/303428763.md) - [The stock market's biggest test in weeks is here](https://longbridge.com/en/news/303076352.md) - [Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 | KMB Stock News](https://longbridge.com/en/news/303807631.md) - [A Tough-Talking Fed Failed to Impress the Markets. What's Next?](https://longbridge.com/en/news/303525021.md) - [The Fed held off on a rate hike. Today's GDP and inflation reports could make waiting harder.](https://longbridge.com/en/news/303553121.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**